| 臺大學術典藏 |
2020-04-27T08:45:07Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Huang Y.-H.; Lee K.-T.; Wang C.-C.; Chau G.-Y.; Lee W.-C.; Ting C.-T.; Lee P.-H.; Wu C.-C.; Huo T.-I.; Liao L.-Y.; Huang S.-F.; Hung C.-F.; Yang S.-S.; Chen R.-C.; Chen C.-H.; Dai C.-Y.; Wang T.-E.; Su C.-W.; Wang J.-H.; Lu S.-N.;Wang J.-H.;Su C.-W.;Wang T.-E.;Dai C.-Y.;Chen C.-H.;Chen R.-C.;Yang S.-S.;Hung C.-F.;Huang S.-F.;Liao L.-Y.;Huo T.-I.;Wu C.-C.;Lee P.-H.;Ting C.-T.;Lee W.-C.;Chau G.-Y.;Wang C.-C.;Lee K.-T.;Huang Y.-H.;Ho M.-C.;Lin S.-M.;Huang G.-T.;Chen K.-Y.;Lin X.-Z.;Hwang J.-I.;Chiou Y.-Y.;Wang C.-K.;Hu J.-T.;Chen S.-C.;Liang P.-C.;Lee R.-C.;Wu D.-K.;Lin C.-Y.;Lin C.-C.;Cheng A.-L.;Hsu C.;Chao Y.;Chen L.-T.;Wang P.-M.;Wang P.-M.;Hong J.-H.;Hsu H.-C.;Chen S.-W.;Leung S.W.;Chia-Hsien Cheng;Wu J.-C.;Wu C.-Y.;Hsu Y.-C.;Hsu C.-W.;Ni Y.-H.;Lin C.-L.;Local Ablation Group, Surveillance Group, Diagnosis Group, Staging Group, Surgery Group, Tace/Tare/Hai Group, Target Therapy/Systemic Therapy Group, Radiotherapy Group, Prevention Group, Drafting Group; Lu S.-N.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; CHIA-HSIEN CHENG; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
| 臺大學術典藏 |
2020-03-03T03:06:51Z |
Generation and characterization of an ascitogenic mesothelin-expressing tumor model
|
Cheng W.-F.;Hung C.-F.;Chai C.-Y.;Chen C.-A.;Lee C.-N.;Su Y.-N.;Wen-Yih Tseng;Hsieh C.-Y.;Shih I.-M.;Wang T.-L.;Wu T.-C.; Cheng W.-F.; Hung C.-F.; Chai C.-Y.; Chen C.-A.; Lee C.-N.; Su Y.-N.; WEN-YIH TSENG; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-19T09:33:41Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Lu S.-N.;Wang J.-H.;Su C.-W.;Wang T.-E.;Dai C.-Y.;Chen C.-H.;Chen R.-C.;Yang S.-S.;Hung C.-F.;Huang S.-F.;Liao L.-Y.;Huo T.-I.;Wu C.-C.;Lee P.-H.;Ting C.-T.;Lee W.-C.;Chau G.-Y.;Wang C.-C.;Lee K.-T.;Huang Y.-H.;Ming-Chih Ho;Lin S.-M.;Huang G.-T.;Chen K.-Y.;Lin X.-Z.;Hwang J.-I.;Chiou Y.-Y.;Wang C.-K.;Hu J.-T.;Chen S.-C.;Liang P.-C.;Lee R.-C.;Wu D.-K.;Lin C.-Y.;Lin C.-C.;Cheng A.-L.;Hsu C.;Chao Y.;Chen L.-T.;Wang P.-M.;Wang P.-M.;Hong J.-H.;Hsu H.-C.;Chen S.-W.;Leung S.W.;Cheng J.C.-H.;Wu J.-C.;Wu C.-Y.;Hsu Y.-C.;Hsu C.-W.;Ni Y.-H.;Lin C.-L.;Local Ablation Group;Surveillance Group;Diagnosis Group;Staging Group;Surgery Group;Tace/Tare/Hai Group;Target Therapy/Systemic Therapy Group;Radiotherapy Group;Prevention Group;Drafting Group; Lu S.-N.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; Chen C.-H.; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; MING-CHIH HO; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group; Surveillance group; Diagnosis group; Staging group; Surgery group; TACE/TARE/HAI group; Target therapy/systemic therapy group; Radiotherapy group; Prevention group; Drafting group |
| 臺大學術典藏 |
2020-02-14T02:50:26Z |
Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene
|
Chen C.-H.;Wang T.-L.;Ji H.;Hung C.-F.;Pardoll D.M.;Wen-Fang Cheng;Ling M.;Wu T.-C.; Chen C.-H.; Wang T.-L.; Ji H.; Hung C.-F.; Pardoll D.M.; WEN-FANG CHENG; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-14T02:50:26Z |
Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen
|
Wen-Fang Cheng;Hung C.-F.;Chai C.-Y.;Hsu K.-F.;He L.;Ling M.;Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-14T02:50:25Z |
Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen
|
Hung C.-F.;Wen-Fang Cheng;Hsu K.-F.;Chai C.-Y.;He L.;Ling M.;Wu T.-C.; Hung C.-F.; WEN-FANG CHENG; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-14T02:50:25Z |
Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen
|
Hsu K.-F.;Hung C.-F.;Wen-Fang Cheng;He L.;Slater L.A.;Ling M.;Wu T.-C.; Hsu K.-F.; Hung C.-F.; WEN-FANG CHENG; He L.; Slater L.A.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-14T02:50:23Z |
Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen
|
Wen-Fang Cheng;Hung C.-F.;Chai C.-Y.;Hsu K.-F.;He L.;Ling M.;Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-14T02:50:23Z |
Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene
|
Wu T.-C.; Ling M.; Rice C.M.; He L.; Hsu K.-F.; Wen-Fang Cheng;Hung C.-F.;Chai C.-Y.;Hsu K.-F.;He L.;Rice C.M.;Ling M.;Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y. |
| 臺大學術典藏 |
2020-02-14T02:50:22Z |
Repeated DNA vaccinations elicited qualitatively different cytotoxic T lymphocytes and improved protective antitumor effects
|
Wen-Fang Cheng;Hung C.F.;Pai S.I.;Hsu K.F.;He L.;Ling M.;Wu T.C.; WEN-FANG CHENG; Hung C.F.; Pai S.I.; Hsu K.F.; He L.; Ling M.; Wu T.C. |
| 臺大學術典藏 |
2020-02-14T02:50:21Z |
Cancer immunotherapy using sindbis virus replicon particles encoding a VP22-antigen fusion
|
Wen-Fang Cheng;Hung C.-F.;Hsu K.-F.;Chai C.-Y.;He L.;Polo J.M.;Slater L.A.;Ling M.;Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Polo J.M.; Slater L.A.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-14T02:50:18Z |
CD8+ T cells, NK cells and IFN-�^ are important for control of tumor with downregulated MHC class I expression by DNA vaccination
|
Wen-Fang Cheng;Hung C.F.;Lin K.Y.;Ling M.;Juang J.;He L.;Lin C.T.;Wu T.-C.; WEN-FANG CHENG; Hung C.F.; Lin K.Y.; Ling M.; Juang J.; He L.; Lin C.T.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-14T02:50:16Z |
Naked RNA vaccine controls tumors with down-regulated MHC class I expression through NK cells and perforin-dependent pathways
|
Wen-Fang Cheng;Hung C.-F.;Lee C.-N.;Su Y.-N.;Chang M.-C.;He L.;Wu T.-C.;Chen C.-A.;Hsieh C.-Y.; WEN-FANG CHENG; Hung C.-F.; Lee C.-N.; Su Y.-N.; Chang M.-C.; He L.; Wu T.-C.; Chen C.-A.; Hsieh C.-Y. |
| 臺大學術典藏 |
2020-02-14T02:50:14Z |
Characterization of DNA vaccines encoding the domains of calreticulin for their ability to elicit tumor-specific immunity and antiangiogenesis
|
Hung C.-F.; Chen C.-A.; Lee C.-N.; Su Y.-N.; Chai C.-Y.; Boyd D.A.K.; Hsieh C.-Y.; Wu T.-C.; Wen-Fang Cheng;Hung C.-F.;Chen C.-A.;Lee C.-N.;Su Y.-N.;Chai C.-Y.;Boyd D.A.K.;Hsieh C.-Y.;Wu T.-C.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-14T02:50:10Z |
Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity
|
Wen-Fang Cheng;Lee C.-N.;Su Y.-N.;Chai C.-Y.;Chang M.-C.;Polo J.M.;Hung C.-F.;Wu T.-C.;Hsieh C.-Y.;Chen C.-A.; WEN-FANG CHENG; Lee C.-N.; Su Y.-N.; Chai C.-Y.; Chang M.-C.; Polo J.M.; Hung C.-F.; Wu T.-C.; Hsieh C.-Y.; Chen C.-A. |
| 臺大學術典藏 |
2020-02-14T02:50:07Z |
Generation and characterization of an ascitogenic mesothelin-expressing tumor model
|
Wu T.-C.; Wang T.-L.; Shih I.-M.; Hsieh C.-Y.; Tseng W.-Y.I.; Su Y.-N.; Lee C.-N.; Chen C.-A.; Chai C.-Y.; Hung C.-F.; WEN-FANG CHENG; Wen-Fang Cheng;Hung C.-F.;Chai C.-Y.;Chen C.-A.;Lee C.-N.;Su Y.-N.;Tseng W.-Y.I.;Hsieh C.-Y.;Shih I.-M.;Wang T.-L.;Wu T.-C. |
| 臺大學術典藏 |
2020-02-12T04:06:33Z |
Naked RNA vaccine controls tumors with down-regulated MHC class I expression through NK cells and perforin-dependent pathways
|
Hsieh C.-Y.;Chen C.-A;Wu T.-C;He L;Chang M.-C;Su Y.-N;CHIEN-NAN LEE;Hung C.-F;Cheng W.-F; Cheng W.-F; Hung C.-F; CHIEN-NAN LEE; Su Y.-N; Chang M.-C; He L; Wu T.-C; Chen C.-A; Hsieh C.-Y. |
| 臺大學術典藏 |
2020-02-12T04:06:29Z |
Characterization of DNA vaccines encoding the domains of calreticulin for their ability to elicit tumor-specific immunity and antiangiogenesis
|
Wu T.-C.; Boyd D.A.K; Hsieh C.-Y; Chai C.-Y; Su Y.-N; CHIEN-NAN LEE; Chen C.-A; Hung C.-F; Cheng W.-F; Wu T.-C.;Hsieh C.-Y;Boyd D.A.K;Chai C.-Y;Su Y.-N;CHIEN-NAN LEE;Chen C.-A;Hung C.-F;Cheng W.-F |
| 臺大學術典藏 |
2020-02-12T04:06:16Z |
Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity
|
Chen C.-A.;Hsieh C.-Y;Wu T.-C;Hung C.-F;Polo J.M;Chang M.-C;Chai C.-Y;Su Y.-N;CHIEN-NAN LEE;Cheng W.-F; Cheng W.-F; CHIEN-NAN LEE; Su Y.-N; Chai C.-Y; Chang M.-C; Polo J.M; Hung C.-F; Wu T.-C; Hsieh C.-Y; Chen C.-A. |
| 臺大學術典藏 |
2020-02-12T04:06:10Z |
Generation and characterization of an ascitogenic mesothelin-expressing tumor model
|
Wu T.-C.;Wang T.-L;Shih I.-M;Hsieh C.-Y;Tseng W.-Y.I;Su Y.-N;CHIEN-NAN LEE;Chen C.-A;Chai C.-Y;Hung C.-F;Cheng W.-F; Cheng W.-F; Hung C.-F; Chai C.-Y; Chen C.-A; CHIEN-NAN LEE; Su Y.-N; Tseng W.-Y.I; Hsieh C.-Y; Shih I.-M; Wang T.-L; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:47Z |
Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene
|
Pardoll D.M.; WEN-FANG CHENG; Ling M.; Wu T.-C.; Chen C.-H.; Wang T.-L.; Ji H.; Hung C.-F.; Pardoll D.M.; WEN-FANG CHENG; Ling M.; Wu T.-C.; Wu T.-C.;Ling M.;WEN-FANG CHENG;Pardoll D.M.;Hung C.-F.;Ji H.;Wang T.-L.;Chen C.-H.; Chen C.-H.; Wang T.-L.; Ji H.; Hung C.-F. |
| 臺大學術典藏 |
2020-02-06T05:22:47Z |
Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen
|
Wu T.-C.;Ling M.;He L.;Hsu K.-F.;Chai C.-Y.;Hung C.-F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:47Z |
Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments
|
Wu T.-C.;Roden R.B.S.;Slater L.A.;Ling M.;He L.;Chai C.-Y.;Hsu K.-F.;Hung C.-F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Slater L.A.; Roden R.B.S.; Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Slater L.A.; Roden R.B.S.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:46Z |
Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand
|
Wu T.-C.;Ling M.;He L.;Chai C.-Y.;WEN-FANG CHENG;Hsu K.-F.;Hung C.-F.; Hung C.-F.; Hsu K.-F.; WEN-FANG CHENG; Chai C.-Y.; He L.; Ling M.; Wu T.-C.; Hung C.-F.; Hsu K.-F.; WEN-FANG CHENG; Chai C.-Y.; He L.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:45Z |
Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen
|
Wu T.-C.;Ling M.;He L.;Hsu K.-F.;Chai C.-Y.;WEN-FANG CHENG;Hung C.-F.; Hung C.-F.; WEN-FANG CHENG; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C.; Hung C.-F.; WEN-FANG CHENG; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C. |
